Increased expression of cell adhesion molecules in inflammatory myopathies: Diagnostic utility and pathogenetic insights

Folia Neuropathologica

Volumn 47, Issue 1, 2009, Pages 33-42

  Jain, Ayushi ^a   Sharma, Mehar C ^a   Sarkar, Chitra ^a   Bhatia, Rohit ^a   Singh, Sumit ^a   Handa, Rohini ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cell adhesion molecules; Dermatomyositis; Idiopathic inflammatory myopathy; Inclusion body myositis; Polymyositis

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; BIOLOGICAL MARKER;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC TEST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; INDIA; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MUSCLE BIOPSY; MUSCLE CELL; PATHOGENESIS; POLYMYOSITIS; PROTEIN ANALYSIS; RETROSPECTIVE STUDY; BIOSYNTHESIS; METABOLISM; MYOSITIS; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIUM;

BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA4BETA1; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MYOSITIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 65649133118     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Appleyard ST, Dunn MZ, Dubowitz V, Rose ML. Increased expression of HLA-ABC class I antigens by muscle fibers in duchenne muscular dystrophy, inflammatory myopathy and other neuromuscular disorders. Lancet 1985; i: 361-363.
2. Archelos JJ, Jung S, Mäurer M, Schmied M, Lassmann H, Tamatani T, Miyasaka M, Toyka KV, Hartung HP. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol 1993; 34: 145-154.
3. Bartoccioni E, Gallucci S, Scuderi F, Ricci E, Servidei S, Broccolini A, Tonali P. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin Exp Immunol 1994; 95: 166-172.
4. Blume G, Pestronk A, Frank B, Johns DR. Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. Brain 1997; 120: 39-45.
5. Bohan A, Peter JB. Polymyositis and Dermatomyositis. N Engl J Med 1975; 292: 344-347.
6. Bohan A, Peter JB. Polymyositis and Dermatomyositis. N Engl J Med 1975; 292: 403-407.
7. Carpenter S, Karpati G. The pathological diagnosis of specific inflammatory myopathies. Brain Pathol 1992; 2: 13-19.
8. Cid MC, Grau JM, Casademont J, Tobías E, Picazo A, Coll-Vinent B, Esparza J, Pedrol E, Urbano-Márquez A. Leucocyte/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (IIM). Clin Exp Immunol 1996; 104: 467-473
9. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of HLA-A,B,C antigens in normal human organs. Transplantation 1984; 38: 287-292.
10. Dahlbom K, Lindberg C, Oldfors A. Inclusion body myositis: morphological clues to correct diagnosis.Neuromuscul. Disord 2002; 12: 853-857.
11. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362: 971-982.
12. Dalakas MC. Advances in the immunobiology and treatment of inflammatory myopathies. Curr Rheumatol Rep 2007; 9: 291-297.
13. Dalakas MC. Sporadic inclusion body myositis - diagnosis, pathogenesis and therapy strategies. Nat Clin Pract Neurol 2006; 2: 437-447.
14. De Bleecker JL, Engel AG. Expression of cell adhesion molecules in inflammatory myopthies and Duchenne dystrophy. J Neuropathol Exp Neurol 1994; 53: 369-376.
15. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T-cell mediated cytotoxicity in myopathies. Hum Pathol 1989; 20: 224-231.
16. Engel AG, Hohlfeld R, Banker BQ. Inflammatory myopathies: the polymyositis and dermatomyostis syndromes. In: Engel AG, Franzini-Armstrong C (eds.). Myology. 3rd ed. Mc Graw Hill Publishing Co Inc, New York, 2004; pp. 1335-1383.
17. Figarella-Branger D, Civatte M, Bartoli C, Pellissier J. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle nerve 2003; 28: 659-682.
18. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP. Inclusion body myositis and myopathies. Ann Neurol 1995; 38: 705-713.
19. Hohlfeld R, Engel AG. The immunobiology of muscle. Immunol Today 1994; 15: 269-274.
20. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Ingrid EL, Rose MR, Vencovsky J, de Visser M, Hughes RA. 119th ENMC international workshop: Trial design in adult indiopathic inflammatory myopathies, with the exclusion of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromusc Disorders 2004; 14: 337-345.
21. Jain A, Sharma MC, Sarkar C, Bhatia R, Singh S, Handa R. MHC class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies. Arch Pathol Lab Med 2007; 131: 1070-1076.
22. Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA, Lipsky PE. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 1994; 37: 992-999.
23. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification and diagnostic criteria. Rheum Dis Clin N Am 2002; 28: 723-741.
24. Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, Danning C, Wada R, Thompson C, Bahtiyar G, Craft J, Hooft Van Huijsduijnen R, Plotz P. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA 2000; 97: 9209-9214.
25. Nishikawa K, Guo YJ, Miyasaka M, Tamatani T, Collins AB, Sy MS, McCluskey RT, Andres G. Antibodies to intercellular adhesion molecule 1/ lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J Exp Med 1993; 177: 667-677.
26. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
27. Stein DP, Dalakas MC. Intercellular adhesion molecule-1 expression is upregulated in patients with dermatomyositis. Ann Neurol 1993; 34: 268.
28. Tews DS, Goebel H. Expression of cell adhesion molecules in inflammatory myopathies. J Neuroimmunol 1995; 59: 185-194.
29. Van der Meulen MFG, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, Dinant HJ, Linssen WHJP, Wokke JHJ, de Visser M. Polymyositis An overdiagnosed entity. Neurology 2003; 61: 316-321.
30. Van der Pas J, Hengstman GJD, Ter Laak HJ, Borm GF, van Engelen BGM. Diagnostic value of MHC Class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry 2004; 75: 136-139.
31. Yednock T, Cannon C, Fritz L, Sanchez-Madrid F, Steinman L, Karin N. Prevention of autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 1992; 356: 63-66.